Feature|Articles|November 15, 2025
Day 3 Recap: Elevate-Derm Fall Conference
Listen
0:00 / 0:00
Key Takeaways
- Cross-specialty collaboration between dermatology and podiatry can significantly improve patient care outcomes, as demonstrated by Shanna Miranti and Larissa Schmidt.
- Recognizing rosacea in patients with skin of color is crucial, with Hilary Baldwin providing diagnostic tips for improved identification.
Catch up on coverage from the third day of the 2025 Elevate-Derm Fall Conference.
Advertisement
To stay informed with the latest conference insights, follow us on social media and
Sister Clinicians Highlight Cross-Specialty Collaboration in Dermatology and Podiatry
At Elevate-Derm Fall, sisters Shanna Miranti, MPAS, PA-C, and Larissa Schmidt, DPM, reviewed the benefits of cross-specialty collaboration for patient care.
Tips for Improving Rosacea Recognition in Patients With Skin of Color at Elevate-Derm
Hilary Baldwin, MD, shares tips for diagnosing rosacea in patients with darker skin tones.
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference
Diego Ruiz Dasilva, MD, shares his expert insights on vitiligo, including treatment options, future therapies, and the importance of combination therapy for effective management.
Treatment Plan Expectations and Previewing the 2026 Pipeline
At Elevate-Derm Fall, Peter Lio, MD, discussed how flexible clinical reasoning and an expanding therapeutic pipeline, particularly hidradenitis suppurativa and atopic dermatitis, are reshaping patient management heading into 2026.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
